防喘汤联合常规西药治疗儿童支气管哮喘缓解期临床观察

Observation of Fangchuan Tang Combined with Routine Western Medicine for the Remission Stage of Bronchial Asthma in Children

目的:观察防喘汤联合常规西药治疗儿童支气管哮喘缓解期的效果,及其对患儿临床症状的改善情况。方法:将86例肺气虚兼脾肾阳虚型支气管哮喘缓解期患儿随机分成对照组和观察组各43例。对照组给予常规治疗,观察组在对照组治疗基础上加用自拟防喘汤,2组均用药至患儿痊愈。治愈后比较2组3月内哮喘的复发率及平均复发次数,观察2组治疗前后中医证候积分的变化。结果:治疗后观察组的支气管哮喘复发率小于对照组(P<0.05),平均复发次数少于对照组(P<0.05)。治疗前,2组中医证候积分比较,差异无统计学意义(P>0.05)。治疗后,观察组的中医证候积分低于对照组和同组治疗前,差异均有统计学意义(P<0.01)。结论:防喘汤联合常规西药治疗肺气虚兼脾肾阳虚型支气管哮喘缓解期,能有效减少支气管哮喘的复发,改善患儿的临床症状。

Objective：To observe the effect of Fangchuan tang combined with routine western medicine on the prevention of the remission stage of bronchial asthma in children and on the improvement of children’s clinical symptoms. Methods：Divided 86 cases of children with the remission stage of bronchial asthma of lung-qi and spleen-kidney yang deficiency into the control group and the observation group randomly, 43 cases in each group. Both groups were given routine treatment, while the treatment group was additionally treated with Fangchuan tang. The two groups both received treatment for three months. After treatment, compared the recurrence rate and the average recurrence frequency of asthma,and observed changes of Chinese medicine syndrome scores in both groups. Results：In the observation group,the recurrence rate of asthma after treatment was lower than that in the control group（P〈0.05）,and the average recurrence frequency after treatment was less than that in the control group（P〈0.05）. After treatment,Chinese medicine syndrome scores in the observation group were lower than those in the control group and those before treatment（P〈0.01）.Conclusion： Fangchuan tang combined with routine western medicine for the remission stage of bronchial asthma in children can effectively reduce the recurrence of bronchial asthma and improve clinical symptoms.